Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19

被引：0
|
作者：
Moingeon, Philippe [1 ]
Desvaux, Emiko [1 ]
Hubert, Sandra [1 ]
Swindle, Jack [1 ]
Laigle, Laurence [1 ]
Guedj, Mickael [1 ]
机构：
[1] Servier, Res & Dev, Suresnes, France
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Drugs for immune modulation; inflammatory molecules; modelling; tissue damage and repair; viral infections;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-1004
引用
收藏
页码：394 / 394
页数：1
相关论文
共 50 条
  • [21] Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
    Rodrigues, Liliana
    Cunha, Renata Bento
    Vassilevskaia, Tatiana
    Viveiros, Miguel
    Cunha, Celso
    MOLECULES, 2022, 27 (09):
  • [22] Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
    Gelemanovic, Andrea
    Vidovic, Tinka
    Stepanic, Visnja
    Trajkovic, Katarina
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 17
  • [23] A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease
    Dou, Lijun
    Xu, Zhenxing
    Xu, Jielin
    Zang, Chengxi
    Su, Chang
    Pieper, Andrew A.
    Leverenz, James B.
    Wang, Fei
    Zhu, Xiongwei
    Cummings, Jeffrey
    Cheng, Feixiong
    NPJ PARKINSONS DISEASE, 2025, 11 (01)
  • [24] Repurposing of Anti-Cancer Drugs Against Moderate and Severe COVID Infection: A Network-Based Systems Biological Approach
    Alzahrani, K. J.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2024, 27 (08) : 950 - 957
  • [25] Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
    Chavda, Vivek P.
    Gajjar, Normi
    Shah, Nirav
    Dave, Divyang J.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2021, 3
  • [26] Application of the PHENotype SIMulator for rapid identification of potential candidates in effective COVID-19 drug repurposing
    Maria, Naomi I.
    Rapicavoli, Rosaria Valentina
    Alaimo, Salvatore
    Bischof, Evelyne
    Stasuzzo, Alessia
    Broek, Jantine A. C.
    Pulvirenti, Alfredo
    Mishra, Bud
    Duits, Ashley J.
    Ferro, Alfredo
    RxCOVEA Framework
    HELIYON, 2023, 9 (03)
  • [27] COVID-19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates
    Ulm, J. Wes
    Nelson, Stanley F.
    TRANSBOUNDARY AND EMERGING DISEASES, 2021, 68 (02) : 313 - 317
  • [28] Diabetes Drug Promising as COVID-19 Lung Inflammation Treatment
    Davidson, Robert
    US PHARMACIST, 2021, 46 (07) : 1 - 1
  • [29] Network medicine framework for identifying drug-repurposing opportunities for COVID-19
    Gysi, Deisy Morselli
    do Valle, Italo
    Zitnik, Marinka
    Ameli, Asher
    Gan, Xiao
    Varol, Onur
    Ghiassian, Susan Dina
    Patten, J. J.
    Davey, Robert A.
    Loscalzo, Joseph
    Barabasi, Albert-Laszlo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (19)
  • [30] Network-Based Identification of Tissue-Specific Regulators and Drug Repurposing Candidates for Coronary Artery Disease
    Cheng, Jenny
    Blencowe, Montgomery
    Lusis, Aldons J.
    Yang, Xia
    CIRCULATION, 2021, 144
12345